Understanding Tuberculosis | Max Healthcare

Get Second Opinion

Doc Connect

Hospital : 
Max Super Speciality Hospital, Saket
  • Robotic Urological Surgery: 15 years journey 
    Dr. Rahul Yadav, Dr. Anant Kumar
  • Robotic surgery is the latest in advanced onco surgical procedures 
    Dr. Harit Chaturvedi
  • Percutaneous balloon aortic valvuloplasty & balloon dilatation of aortic coarctation in a 10 year old child 
    Dr. Neeraj Awasthy, Dr. Sushil Shukla
  • Role of CT/MR imaging and echocardiography in evaluation of valsalva sinus aneurysm 
    Dr. Reena Anand, Dr. Raj Kumar, Dr. Divya Malhotra, Dr. Bharat Aggarwal
  • Risk factors for patients undergoing treatment for Breast Cancer
    Ms. Kanika Arora, Ms. Ritika Samaddar
  • Radiology Case of The Month 
    Dr. Nafisa Shakir Batta, Dr. Dhruv Jain
October, 2015 :15
Emergency Call Button

DELHI / NCR : 011-4055 4055

MOHALI : 0172-665 2666

DEHRADUN : 0135-667 3666

BATHINDA : 0164-660 1666

New Stent Prices

Sr. No. Type Name of Manufacturer Price to Patient (Including local taxes per NPPA order) for Delhi, UP & Uttarakhand Price to Patient (Including local taxes per NPPA order) for Haryana Price to Patient (Including local taxes per NPPA order) for Punjab
1 Xience Prime Drug Eluting Stent Abbott Healthcare Pvt.Ltd 24999 24999 24999.00
2 Xience V Everolimus Eluting Coronary Stent Abbott Healthcare Pvt.Ltd 24999 24999 24999.00
3 Endeavor Sprint Stent India Medtronic Pvt. Ltd 31080 31080 31635.00
4 Biomime Drug Eluting Stent Meril Lifesciences Ltd 31080 31080 31635.00
5 Metafor Drug Eluting Stent Meril Lifesciences Ltd 31080 31080 31635.00
6 Supraflex Sirolimus Eluting Stent Sahajanand Medical Technologies Pvt Ltd 31080 31080 31635.00
7 Yukon Choice Flex Stent Translumina Therapeutics LLP 31080 31154 31635.00
8 Cobal+C Mini Stent Relisys Medical Devices Ltd 7623 7641 7759

Understanding Tuberculosis

Home >> Blogs >> Internal Medicine >> Understanding Tuberculosis

Clinical Directorate

For more info please call 011-4732 6969, 9999 777 754, or mail at homecare@maxhealthcare.com


Understanding Tuberculosis

Prashant Saxena - Max Smart Saket
HoD (Pulmonology & Sleep Medicine) & Principal Consultant (Critical Care Medicine)
Critical Care, Pulmonology

Approximately 40% of the Indian population is infected with TB bacteria, the vast majority of whom have latent rather than active TB. World Health Organization (WHO) has estimated that around 300,000 people die from TB each year in India. According to DAHW (German Leprosy & Tuberculosis Relief Association), every fifth new tuberculosis case in the world lives in the Indian subcontinent. Shocking, right? Tuberculosis or TB is one of the most grave and major diseases facing India today. And that is the reason each and every citizen must be well aware of this malady.

FAQs about TB

What is TB?

Tuberculosis is a bacterial infection that usually attacks the lungs first and then can spread to any organ of the body. If not treated properly, TB disease can be fatal. This disease was once associated with the poor, however today, it is known to afflict all classes of society.

What are the Precautions?

While TB is a dangerous and grave disease, taking a few simple precautions can help you in the long run. Always cover your mouth and nose when you cough or sneeze. Try and use a mask while you’re in congested public places like trains, buses, stations etc. If you can, use a fan or open the windows at home for cross-ventilation of air. You may go outside of your home in the open air without your mask.

What are the Symptoms?

TB is essentially a respiratory disease. Here are the symptoms you need to look out for:

  • Pain in the chest when you breathe or cough.
  • Cough that lasts for three weeks or more
  • Coughing up blood
  • Unintentional weight loss
  • Fatigue
  • FeverNight sweats
  • Chills
  • Loss of appetite

What is the Cure?

DOTS (Direct Observed Treatment) The DOTS strategy along with the other components of the Stop TB strategy, implemented under the Revised National Tuberculosis Control Programme (RNTCP) in India, is a comprehensive package for TB control, prescribed by the WHO. According to TBC India, the DOTS strategy is cost-effective and is today the international standard for TB control programmes. To date, more than 180 countries are implementing the DOTS strategy. India has adapted and tested the DOTS strategy in various parts of the country since 1993, with excellent results, and by March 2006 nationwide DOTS coverage has been achieved. Modern anti-TB treatment can cure virtually all patients. It is, however, very important that the treatment be taken for the prescribed duration, which in every case is a minimum of 6 months. Because treatment is for such a long duration and the patients feel better after just 1-2 months, treatment is often interrupted. This can lead to the bacteria becoming resistant to the drug administered and will require a stronger dose of the medicine to have effect.